-
Analysis of the clinical characteristics of dabigatran-induced oesophagitis
Author: Zhou, Yulu; Su, Yanhong; Li, Zuojun; Wu, Cuifang; Sun, Wei; Wang, Chunjiang
Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E24-E28. DOI: 10.1136/ejhpharm-2021-002889
-
Haemolytic anaemia induced by flutamide: a case report
Author: Sun, Yu; Zhu, Suyan; Hu, Qi; Xu, Ping
Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E109-E111. DOI: 10.1136/ejhpharm-2021-002936
-
Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies +/- other therapies in lung cancer: a systematic review and meta-analysis
Author: Shen, Xiang; Huang, Shangke; Xiao, Hua; Zeng, Shan; Liu, Jiexing; Ran, Zhuolan; Xiong, Bin
Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue 1, pp. 3-8. DOI: 10.1136/ejhpharm-2021-002803
-
Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis
Author: Tsui, Leo; Ye, Peiying; Xu, Shiling; Lin, Yuan; Chen, Bin; Chen, Sy-Ping; Cheng, Ruoh-Yi
Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E82-E89. DOI: 10.1136/ejhpharm-2022-003333
-
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients
Author: Yang, QiaoWei; Hu, Yan; Zhang, XuanLing; Zhang, XiaoMin; Li, Xingang; Dai, Haibin
Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E90-E96. DOI: 10.1136/ejhpharm-2022-003357
-
Investigation on the knowledge level of the rational application of antimicrobial drugs among pharmacists in medical institutions in Shanxi Province
Author: Xue, Zhimin; Guo, Zhixing; Zhao, Ruiling
Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. 30, Issue E1, pp. E19-E23. DOI: 10.1136/ejhpharm-2021-002885
-
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients
Author: Bai, Jing; Wen, Aiping; Li, Zhe; Li, Xingang; Duan, Meili
Journal: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; Vol. , Issue , pp. -. DOI: 10.1136/ejhpharm-2022-003403